{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:53:00Z","timestamp":1777333980772,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["Uniwersytet Medyczny w Bialymstoku"],"award-info":[{"award-number":["Uniwersytet Medyczny w Bialymstoku"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07479-y","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:29:36Z","timestamp":1765967376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary evaluation of oxyntomodulin as a biomarker for metabolic risk stratification in adults with obesity"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3806-9849","authenticated-orcid":false,"given":"Mateusz","family":"Zwierz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Buczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ko\u015bciuszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Sobieska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Siewko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam Jacek","family":"Kr\u0119towski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pop\u0142awska-Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"7479_CR1","unstructured":"World Obesity Federation Lobstein T, Powis J, Thompson R. Rachel Jackson-Leach. World obesity atlas 2025 Overweight, obesity and non-communicable diseases. 3 Waterhouse Square, 138\u201342 Holborn, London EC1N 2SW, 2025."},{"key":"7479_CR2","doi-asserted-by":"publisher","first-page":"102848","DOI":"10.1016\/j.eclinm.2024.102848","volume":"76","author":"X-D Zhou","year":"2024","unstructured":"Zhou X-D, Chen Q-F, Yang W, et al. Burden of disease attributable to high body mass index: an analysis of data from the global burden of disease study 2021. EClinicalMedicine. 2024;76:102848.","journal-title":"EClinicalMedicine"},{"key":"7479_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2362.1988.tb01046.x","volume":"18","author":"SCHJOLDAGERBTG BALDISSERA","year":"1988","unstructured":"BALDISSERA SCHJOLDAGERBTG, MORTENSEN FGA, HOLST PE. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest. 1988;18:499\u2013503.","journal-title":"Eur J Clin Invest"},{"key":"7479_CR4","doi-asserted-by":"publisher","first-page":"170955","DOI":"10.1016\/j.peptides.2023.170955","volume":"162","author":"Y Zhihong","year":"2023","unstructured":"Zhihong Y, Chen W, Qianqian Z, et al. Emerging roles of oxyntomodulin-based glucagon-like peptide-1\/glucagon co-agonist analogs in diabetes and obesity. Peptides (NY). 2023;162:170955.","journal-title":"Peptides (NY)"},{"key":"7479_CR5","doi-asserted-by":"crossref","unstructured":"Kueh MTW, Chong MC, Miras AD, le Roux CW. Oxyntomodulin physiology and its therapeutic development in obesity and associated complications. J Physiol. 2024.","DOI":"10.1113\/JP287407"},{"key":"7479_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7479_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5603\/cd.102456","volume":"14","author":"J Go\u0142acki","year":"2025","unstructured":"Go\u0142acki J, Witczak K, G\u00f3recki K, et al. Bioimpedance body composition analysis in estimating insulin resistance in women with overweight and obesity (LUCAS 1.1): A retrospective analysis. Clin Diabetol. 2025;14:5\u201311.","journal-title":"Clin Diabetol"},{"key":"7479_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/0976-500X.83280","volume":"2","author":"LM H","year":"2011","unstructured":"H LM. Comparison of McAuley\/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus. J Pharmacol Pharmacother. 2011;2:165\u20139.","journal-title":"J Pharmacol Pharmacother"},{"key":"7479_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.26444\/aaem\/109225","volume":"27","author":"S P\u0142aczkowska","year":"2020","unstructured":"P\u0142aczkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Estimation of reference intervals of insulin resistance (HOMA), insulin sensitivity (Matsuda), and insulin secretion sensitivity indices (ISSI-2) in Polish young people. Ann Agric Environ Med. 2020;27:248\u201354.","journal-title":"Ann Agric Environ Med"},{"key":"7479_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1385\/ENDO:21:2:137","volume":"21","author":"OM Hauache","year":"2003","unstructured":"Hauache OM, Vieira JGH. Fasting insulin concentration is highly correlated with quantitative insulin sensitivity check index. Endocrine. 2003;21:137\u20138.","journal-title":"Endocrine"},{"key":"7479_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.peptides.2017.09.018","volume":"100","author":"JJ Holst","year":"2018","unstructured":"Holst JJ, Albrechtsen NJW, Gabe MBN, Rosenkilde MM. Oxyntomodulin: actions and role in diabetes. Peptides (NY). 2018;100:48\u201353.","journal-title":"Peptides (NY)"},{"key":"7479_CR12","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.1039\/C9OB01132C","volume":"17","author":"L Zhao","year":"2019","unstructured":"Zhao L, Wang B, Wang L, Zhao X, Chen Z, Sun L. Design, screening and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects. Org Biomol Chem. 2019;17:7760\u201371.","journal-title":"Org Biomol Chem"},{"key":"7479_CR13","doi-asserted-by":"publisher","first-page":"117651","DOI":"10.1016\/j.lfs.2020.117651","volume":"253","author":"Z Pei","year":"2020","unstructured":"Pei Z, Zhou D, Yan J, Wang S, Yang X, Pei Z. Design and characterization of novel oxyntomodulin derivatives with potent dual GLP-1\/glucagon receptor activation and prolonged antidiabetic effects. Life Sci. 2020;253:117651.","journal-title":"Life Sci"},{"key":"7479_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physrev.00031.2014","volume":"97","author":"RE Steinert","year":"2017","unstructured":"Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N, Ghrelin CCK. GLP-1, and PYY(3\u201336): secretory controls and physiological roles in eating and glycemia in Health, Obesity, and after RYGB. Physiol Rev. 2017;97:411\u201363.","journal-title":"Physiol Rev"},{"key":"7479_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/psc.1328","volume":"17","author":"A Santoprete","year":"2011","unstructured":"Santoprete A, Capit\u00f2 E, Carrington PE, et al. DPP-IV\u2010resistant, long\u2010acting oxyntomodulin derivatives. J Pept Sci. 2011;17:270\u201380.","journal-title":"J Pept Sci"},{"key":"7479_CR16","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/db10-1707","volume":"60","author":"D Lamers","year":"2011","unstructured":"Lamers D, Famulla S, Wronkowitz N, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60:1917\u201325.","journal-title":"Diabetes"},{"key":"7479_CR17","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.2337\/dc13-0496","volume":"36","author":"H Sell","year":"2013","unstructured":"Sell H, Bl\u00fcher M, Kl\u00f6ting N, et al. Adipose dipeptidyl Peptidase-4 and obesity. Diabetes Care. 2013;36:4083\u201390.","journal-title":"Diabetes Care"},{"key":"7479_CR18","doi-asserted-by":"publisher","first-page":"e92222","DOI":"10.1371\/journal.pone.0092222","volume":"9","author":"F Yang","year":"2014","unstructured":"Yang F, Zheng T, Gao Y, et al. Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China National diabetes and metabolic disorders study. PLoS ONE. 2014;9:e92222.","journal-title":"PLoS ONE"},{"key":"7479_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.peptides.2014.09.006","volume":"61","author":"A Stengel","year":"2014","unstructured":"Stengel A, Goebel-Stengel M, Teuffel P, et al. Obese patients have higher Circulating protein levels of dipeptidyl peptidase IV. Peptides (NY). 2014;61:75\u201382.","journal-title":"Peptides (NY)"},{"key":"7479_CR20","unstructured":"Naserallah R, Kasabri V, Akour A, Khawaja N, Naffa R, Bustanji Y. The levels of Oxytocin and Oxyntomodulin, adiposity and blood indices in pharmacotherapy Naive diabetic and Non-Diabetic patients with metabolic syndrome. 2018."},{"key":"7479_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ebiom.2016.03.034","volume":"7","author":"NJ Wewer Albrechtsen","year":"2016","unstructured":"Wewer Albrechtsen NJ, Hornburg D, Albrechtsen R, et al. Oxyntomodulin identified as a marker of type 2 diabetes and gastric bypass surgery by Mass-spectrometry based profiling of human plasma. EBioMedicine. 2016;7:112\u201320.","journal-title":"EBioMedicine"},{"key":"7479_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13105-014-0375-7","volume":"71","author":"JSG Mu\u00f1oz","year":"2015","unstructured":"Mu\u00f1oz JSG, Rodr\u00edguez DJ, Morante JJH. Diurnal rhythms of plasma GLP-1 levels in normal and overweight\/obese subjects: lack of effect of weight loss. J Physiol Biochem. 2015;71:17\u201328.","journal-title":"J Physiol Biochem"},{"key":"7479_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2840-9-17","volume":"9","author":"M Yamaoka-Tojo","year":"2010","unstructured":"Yamaoka-Tojo M, Tojo T, Takahira N, et al. Elevated Circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol. 2010;9:17.","journal-title":"Cardiovasc Diabetol"},{"key":"7479_CR24","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41366-021-00808-3","volume":"45","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Hu Z, Kocak M, et al. Associations of prenatal metabolomics profiles with early childhood growth trajectories and obesity risk in African americans: the CANDLE study. Int J Obes. 2021;45:1439\u201347.","journal-title":"Int J Obes"},{"key":"7479_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ijo.2017.289","volume":"42","author":"SK Vasan","year":"2018","unstructured":"Vasan SK, Osmond C, Canoy D, et al. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes. 2018;42:850\u20137.","journal-title":"Int J Obes"},{"key":"7479_CR26","doi-asserted-by":"crossref","unstructured":"Liu C-A, Liu T, Ruan G-T, et al. The relationship between fat distribution in central region and comorbidities in obese people: based on NHANES 2011\u20132018. Front Endocrinol (Lausanne) 2023; 14.","DOI":"10.3389\/fendo.2023.1114963"},{"key":"7479_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/oby.2009.267","volume":"18","author":"JC Hannukainen","year":"2010","unstructured":"Hannukainen JC, Kalliokoski KK, Borra RJM, et al. Higher free fatty acid uptake in visceral than in abdominal subcutaneous fat tissue in men. Obesity. 2010;18:261\u20135.","journal-title":"Obesity"},{"key":"7479_CR28","doi-asserted-by":"crossref","unstructured":"Sajjadi SF, Mirzababaei A, Ghodoosi nasim et, al. Adherence to a low carbohydrate diet May modify resting metabolic rate among overweight and obese women. 2020.","DOI":"10.21203\/rs.3.rs-47451\/v1"},{"key":"7479_CR29","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.3390\/jcm13195862","volume":"13","author":"E Gitsi","year":"2024","unstructured":"Gitsi E, Kokkinos A, Konstantinidou SK, Livadas S, Argyrakopoulou G. The relationship between resting metabolic rate and body composition in people living with overweight and obesity. J Clin Med. 2024;13:5862.","journal-title":"J Clin Med"},{"key":"7479_CR30","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ijo.2010.234","volume":"34","author":"AG Dulloo","year":"2010","unstructured":"Dulloo AG, Jacquet J, Solinas G, Montani J-P, Schutz Y. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes. 2010;34:S4\u201317.","journal-title":"Int J Obes"},{"key":"7479_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40200-020-00563-8","volume":"19","author":"S Cuschieri","year":"2020","unstructured":"Cuschieri S, Grech S. Assessing impaired fasting blood glucose criteria for high-risk dysglycaemic populations: an experience from a European population state. J Diabetes Metab Disord. 2020;19:775\u201381.","journal-title":"J Diabetes Metab Disord"},{"key":"7479_CR32","unstructured":"Venugopal SK, Mowery ML, Jialal I, Biochemistry C. Peptide. StatPearls Publishing, Treasure Island (FL). 2023."},{"key":"7479_CR33","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.3390\/jcm13195866","volume":"13","author":"N Batmunkh","year":"2024","unstructured":"Batmunkh N, Enkhtugs K, Munkhbat K, et al. Cardiovascular risk across glycemic categories: insights from a nationwide screening in Mongolia, 2022\u20132023. J Clin Med. 2024;13:5866.","journal-title":"J Clin Med"},{"key":"7479_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/archdischild-2013-303967","volume":"99","author":"L-H Chen","year":"2014","unstructured":"Chen L-H, Zhu W-F, Liang L, et al. Relationship between glycated haemoglobin and subclinical atherosclerosis in obese children and adolescents. Arch Dis Child. 2014;99:39\u201345.","journal-title":"Arch Dis Child"},{"key":"7479_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1210\/jc.2009-2054","volume":"95","author":"RD Carr","year":"2010","unstructured":"Carr RD, Larsen MO, Jelic K, et al. Secretion and dipeptidyl Peptidase-4-Mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to Lean, nondiabetic men. J Clin Endocrinol Metab. 2010;95:872\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"7479_CR36","doi-asserted-by":"crossref","unstructured":"Brubaker PL. The molecular determinants of Glucagon-like peptide secretion by the intestinal L cell. Endocrinology. 2022; 163.","DOI":"10.1210\/endocr\/bqac159"},{"key":"7479_CR37","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1210\/clinem\/dgab098","volume":"106","author":"SE Stinson","year":"2021","unstructured":"Stinson SE, Jonsson AE, Lund MAV, et al. Fasting plasma GLP-1 is associated with Overweight\/Obesity and cardiometabolic risk factors in children and adolescents. J Clin Endocrinol Metab. 2021;106:1718\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"7479_CR38","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/nu5062019","volume":"5","author":"P Patel","year":"2013","unstructured":"Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients. 2013;5:2019\u201327.","journal-title":"Nutrients"},{"key":"7479_CR39","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","volume":"86","author":"M-B Toft-Nielsen","year":"2001","unstructured":"Toft-Nielsen M-B, Damholt MB, Madsbad S, et al. Determinants of the impaired secretion of Glucagon-Like Peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab. 2001;86:3717\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"7479_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.26444\/ms\/169786","volume":"26","author":"MM Derezi\u0144ski","year":"2023","unstructured":"Derezi\u0144ski MM, Przeorski K, Kliniec K, Mendowski M, Zuziak P. Hormonal changes in obesity. Environ Med. 2023;26:20\u20135.","journal-title":"Environ Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07479-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07479-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07479-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:29:39Z","timestamp":1765967379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07479-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7479"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07479-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Local Ethics Committee of the Medical University of Bialystok, Poland (approval number APK.002.364.2021). Written informed consent was obtained from all participants prior to their inclusion, ensuring adherence to ethical standards and respect for participant autonomy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors agreed for publication of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1400"}}